Researches on animal models suggest that increased numbers of infiltrating CD4+ T cells in brain tissue after IS are associated with poor prognosis of stroke, but anti-CD4+ T cells do not improve the severity of infarction (Zhang et al., 2022). The gene discussed is CD4; the disease is Stroke.